Researchers Published New Findings on Ehlers-Danlos Syndrome
Three studies identified distinct physiological traits in patients with hypermobile Ehlers-Danlos syndrome.
Updated on Sept. 23, 2026 in Arthritis
Live Poll
Should medical researchers prioritize studying multi-system symptoms over focusing solely on pain management?
Researchers have released three new studies detailing symptom profiles and physiological markers associated with hypermobile Ehlers-Danlos syndrome. The findings include evidence of unique androgen levels in women and specific challenges regarding sleep apnea treatment efficacy.
Why it matters
Because the genetic causes of the condition remain unidentified, these studies are critical for mapping disease progression and developing a standardized diagnostic test. Improved diagnostic accuracy could eventually lead to more effective, targeted treatments for the millions of people affected.
The research drew from a cohort of more than 80 study participants to compare those with hypermobile Ehlers-Danlos syndrome against those with hypermobility spectrum disorder and non-hypermobile control groups.
The players
Carle Health
This Urbana, Illinois-based healthcare system served as one of the key institutions participating in the research efforts.
St. Jude Research Hospital
Based in Memphis, this hospital contributed to the research collaboration aimed at understanding disease progression.
University of Arizona
This Arizona-based academic institution provided resources and expertise for the multi-center study on Ehlers-Danlos syndrome.
The details
The research team collected and analyzed blood, urine, and skin biosamples to examine physiological differences. The studies found that while hypermobile patients with sleep apnea are highly compliant with CPAP use, they do not experience the same level of improvement in daytime sleepiness as non-hypermobile patients.
Timeline
September 23, 2026: The research was published in the Journal of Steroid Biochemistry and Molecular Biology.
The Big Picture
These findings provide a vital update to the clinical research criteria for hypermobile Ehlers-Danlos syndrome. This discovery marks a departure from traditional diagnosis, which has historically relied on physical exams rather than biological markers.
The research highlights that patients with hypermobile Ehlers-Danlos syndrome may face persistent sleepiness despite CPAP adherence, suggesting a need for specialized monitoring in sleep clinics. These findings may eventually change how clinicians approach symptom management and treatment expectations for the syndrome.
The takeaway
Patients who experience hypermobility symptoms without pain should still seek evaluation, as physiological differences exist even in the absence of chronic pain. Researchers remain focused on moving toward a definitive diagnostic blood or tissue test to replace current subjective clinical assessments.
Further reading
For more information on the management of joint conditions, visit our Arthritis section.
More information
Read the complete Journal study on androgen levels in the Journal of Steroid Biochemistry and Molecular Biology.
Source note: This article includes information reported by Technology Networks.
Live Poll
Should medical researchers prioritize studying multi-system symptoms over focusing solely on pain management?
